BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10934226)

  • 1. The Rho family guanine nucleotide exchange factor Vav-2 regulates the development of cell-mediated cytotoxicity.
    Billadeau DD; Mackie SM; Schoon RA; Leibson PJ
    J Exp Med; 2000 Aug; 192(3):381-92. PubMed ID: 10934226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific subdomains of Vav differentially affect T cell and NK cell activation.
    Billadeau DD; Mackie SM; Schoon RA; Leibson PJ
    J Immunol; 2000 Apr; 164(8):3971-81. PubMed ID: 10754287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vav2 activates c-fos serum response element and CD69 expression but negatively regulates nuclear factor of activated T cells and interleukin-2 gene activation in T lymphocyte.
    Tartare-Deckert S; Monthouel MN; Charvet C; Foucault I; Van Obberghen E; Bernard A; Altman A; Deckert M
    J Biol Chem; 2001 Jun; 276(24):20849-57. PubMed ID: 11262396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vav family proteins couple to diverse cell surface receptors.
    Moores SL; Selfors LM; Fredericks J; Breit T; Fujikawa K; Alt FW; Brugge JS; Swat W
    Mol Cell Biol; 2000 Sep; 20(17):6364-73. PubMed ID: 10938113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor.
    Foucault I; Le Bras S; Charvet C; Moon C; Altman A; Deckert M
    Blood; 2005 Feb; 105(3):1106-13. PubMed ID: 15345594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A guanine nucleotide exchange factor-independent function of Vav1 in transcriptional activation.
    Kuhne MR; Ku G; Weiss A
    J Biol Chem; 2000 Jan; 275(3):2185-90. PubMed ID: 10636924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vav2 is an activator of Cdc42, Rac1, and RhoA.
    Abe K; Rossman KL; Liu B; Ritola KD; Chiang D; Campbell SL; Burridge K; Der CJ
    J Biol Chem; 2000 Apr; 275(14):10141-9. PubMed ID: 10744696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes.
    Doody GM; Billadeau DD; Clayton E; Hutchings A; Berland R; McAdam S; Leibson PJ; Turner M
    EMBO J; 2000 Nov; 19(22):6173-84. PubMed ID: 11080163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vav1 and Ly-GDI two regulators of Rho GTPases, function cooperatively as signal transducers in T cell antigen receptor-induced pathways.
    Groysman M; Hornstein I; Alcover A; Katzav S
    J Biol Chem; 2002 Dec; 277(51):50121-30. PubMed ID: 12386169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic defects in TCR signaling in a Vav-1-null Jurkat T-cell line.
    Cao Y; Janssen EM; Duncan AW; Altman A; Billadeau DD; Abraham RT
    EMBO J; 2002 Sep; 21(18):4809-19. PubMed ID: 12234921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional T-cell receptor signaling pathway is required for p95vav activity.
    Wu J; Katzav S; Weiss A
    Mol Cell Biol; 1995 Aug; 15(8):4337-46. PubMed ID: 7623828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vav-induced activation of the human IFN-gamma gene promoter is mediated by upregulation of AP-1 activity.
    Kaminuma O; Elly C; Tanaka Y; Mori A; Liu YC; Altman A; Miyatake S
    FEBS Lett; 2002 Mar; 514(2-3):153-8. PubMed ID: 11943142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing.
    Billadeau DD; Brumbaugh KM; Dick CJ; Schoon RA; Bustelo XR; Leibson PJ
    J Exp Med; 1998 Aug; 188(3):549-59. PubMed ID: 9687532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras.
    Khosravi-Far R; Chrzanowska-Wodnicka M; Solski PA; Eva A; Burridge K; Der CJ
    Mol Cell Biol; 1994 Oct; 14(10):6848-57. PubMed ID: 7935402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors.
    Heo J; Thapar R; Campbell SL
    Biochemistry; 2005 May; 44(17):6573-85. PubMed ID: 15850391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs.
    Margolis B; Hu P; Katzav S; Li W; Oliver JM; Ullrich A; Weiss A; Schlessinger J
    Nature; 1992 Mar; 356(6364):71-4. PubMed ID: 1531699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity.
    Galandrini R; Palmieri G; Piccoli M; Frati L; Santoni A
    J Immunol; 1999 Mar; 162(6):3148-52. PubMed ID: 10092764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC.
    Arthur WT; Ellerbroek SM; Der CJ; Burridge K; Wennerberg K
    J Biol Chem; 2002 Nov; 277(45):42964-72. PubMed ID: 12221096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hSiah2 is a new Vav binding protein which inhibits Vav-mediated signaling pathways.
    Germani A; Romero F; Houlard M; Camonis J; Gisselbrecht S; Fischer S; Varin-Blank N
    Mol Cell Biol; 1999 May; 19(5):3798-807. PubMed ID: 10207103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins.
    Movilla N; Bustelo XR
    Mol Cell Biol; 1999 Nov; 19(11):7870-85. PubMed ID: 10523675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.